The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis
Abstract
G protein-coupled receptor (GPCR) oligomerization is a growing concept that has emerged from several studies suggesting that GPCRs can form both homo- and heterodimers. Using both coimmunoprecipitation and bioluminescence resonance energy transfer (BRET) approaches, we established that the vasopressin V1a, V2, and the oxytocin receptors exist as homo- and hetero-dimers in transfected human embryonic kidney 293T cells. Each receptor protomer had a similar propensity to form homo- and heterodimers, indicating that their relative expression levels may determine the homo-/heterodimer ratio. The finding that immature forms of the receptor can be immunoprecipitated as homo- and heterodimers and the detection by BRET of such oligomer in endoplasmic reticulum-enriched fractions suggest that the oligomerization processes take place early during biosynthesis. Treatment with agonists or antagonists did not modify the BRET among any of the vasopressin and oxytocin receptor pairs studied, indicating that the dimerization state of the receptors is not regulated by ligand binding once they have reached the cell surface. Taken together, these results strongly support the notion that GPCR dimerization is a constitutive process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Molecular tinkering of G protein-coupled receptors: an evolutionary success
Bockaert, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1723 · Cited by 1,550
Nelson, G., Chandrashekar, J., Hoon, M. A., Feng, L., Zhao, G., Ryba, N. J. P., & Zuker, C. S. (2002) · Nature · doi:10.1038/nature726 · Cited by 1,518
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
Kunishima, N., Shimada, Y., Tsuji, Y., Sato, T., Yamamoto, M., Kumasaka, T., Nakanishi, S., Jingami, H., & Morikawa, K. (2000) · Nature · doi:10.1038/35039564 · Cited by 1,249
GABAB-receptor subtypes assemble into functional heteromeric complexes
Kaupmann, K., Malitschek, B., Schuler, V., Heid, J., Froestl, W., Beck, P., Mosbacher, J., Bischoff, S., Kulik, A., Shigemoto, R., et al. (1998) · Nature · doi:10.1038/25360 · Cited by 1,195
Heterodimerization is required for the formation of a functional GABAB receptor
White, J. H., Wise, A., Main, M. J., Green, A., Fraser, N. J., Disney, G. H., Barnes, A. A., Emson, P., Foord, S. M., & Marshall, F. H. (1998) · Nature · doi:10.1038/25354 · Cited by 1,182
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,166
GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2
Jones, K. A., Borowsky, B., Tamm, J. A., Craig, D. A., Durkin, M. M., Dai, M., Yao, W.-J., Johnson, M., Gunwaldsen, C., Huang, L.-Y., et al. (1998) · Nature · doi:10.1038/25348 · Cited by 1,079
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000) · Science · doi:10.1126/science.288.5463.154 · Cited by 888
A Trafficking Checkpoint Controls GABAB Receptor Heterodimerization
Margeta-Mitrovic, M., Jan, Y. N., & Jan, L. Y. (2000) · Neuron · doi:10.1016/s0896-6273(00)00012-x · Cited by 680
Oligomerization of G-protein-coupled transmitter receptors
Bouvier, M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067575 · Cited by 669
Self-citationAngers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., & Bouvier, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3684 · Cited by 638
Self-citationMellon, P., Parker, V., Gluzman, Y., & Maniatis, T. (1981) · Cell · doi:10.1016/0092-8674(81)90411-6 · Cited by 598
G-Protein-coupled receptor oligomerization and its potential for drug discovery
George, S. R., O'Dowd, B. F., & Lee, S. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd913 · Cited by 588
Dimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function
Angers, S., Salahpour, A., & Bouvier, M. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091701.082314 · Cited by 586
Self-citationOligomerization of μ- and δ-Opioid Receptors
George, S. R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G., & O'Dowd, B. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000345200 · Cited by 556
Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers
Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., & Patel, Y. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7862 · Cited by 527
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
AbdAlla, S., Lother, H., & Quitterer, U. (2000) · Nature · doi:10.1038/35024095 · Cited by 503
Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptors
Pierce, K. L., & Lefkowitz, R. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094577 · Cited by 476
Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains
Dann, C. E., Hsieh, J.-C., Rattner, A., Sharma, D., Nathans, J., & Leahy, D. J. (2001) · Nature · doi:10.1038/35083601 · Cited by 473
Dopamine D 1 and adenosine A 1 receptors form functionally interacting heteromeric complexes
Ginés, S., Hillion, J., Torvinen, M., Le Crom, S., Casadó, V., Canela, E. I., Rondin, S., Lew, J. Y., Watson, S., Zoli, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150241097 · Cited by 445
Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
Mellado, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2497 · Cited by 432
Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy
Gomes, I., Jordan, B. A., Gupta, A., Trapaidze, N., Nagy, V., & Devi, L. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-j0007.2000 · Cited by 403
Vasopressin and oxytocin receptors in the central nervous system
Tribollet, E., & Barberis, C. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.60 · Cited by 399
Ayoub, M. A., Couturier, C., Lucas-Meunier, E., Angers, S., Fossier, P., Bouvier, M., & Jockers, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200729200 · Cited by 322
Self-citationG-protein-coupled receptors function as oligomers in vivo
Overton, M. C., & Blumer, K. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00386-9 · Cited by 317
Structural bases of vasopressin/oxytocin receptor function
Barberis, C., Mouillac, B., & Durroux, T. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560223 · Cited by 311
Self-citationPetäjä-Repo, U. E., Hogue, M., Laperrière, A., Walker, P., & Bouvier, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13727 · Cited by 289
Self-citationPfeiffer, M., Koch, T., Schröder, H., Laugsch, M., Höllt, V., & Schulz, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110373200 · Cited by 263
McVey, M., Ramsay, D., Kellett, E., Rees, S., Wilson, S., Pope, A. J., & Milligan, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008902200 · Cited by 257
Dwyer, N. D., Troemel, E. R., Sengupta, P., & Bargmann, C. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81173-3 · Cited by 248
Mutant α subunits of Gi2 inhibit cyclic AMP accumulation
Wong, Y. H., Federman, A., Pace, A. M., Zachary, I., Evans, T., Pouysségur, J., & Bourne, H. R. (1991) · Nature · doi:10.1038/351063a0 · Cited by 235
Issafras, H., Angers, S., Bulenger, S., Blanpain, C., Parmentier, M., Labbé-Jullié, C., Bouvier, M., & Marullo, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202386200 · Cited by 209
Self-citationHow activated receptors couple to G proteins
Hamm, H. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011099798 · Cited by 203
Kroeger, K. M., Hanyaloglu, A. C., Seeber, R. M., Miles, L. E. C., & Eidne, K. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011311200 · Cited by 190
Potassium Channel ä and β Subunits Assemble in the Endoplasmic Reticulum
Nagaya, N., & Papazian, D. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.3022 · Cited by 167
Terada, Y., Tomita, K., Nonoguchi, H., Yang, T., & Marumo, F. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116838 · Cited by 135
Bazin, H., Préaudat, M., Trinquet, E., & Mathis, G. (2001) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/s1386-1425(01)00493-0 · Cited by 129
Cheng, Z.-J., & Miller, L. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105668200 · Cited by 127
Hilairet, S., Foord, S. M., Marshall, F. H., & Bouvier, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102722200 · Cited by 114
Self-citationFluorescence techniques: shedding light on ligand–receptor interactions
Hovius, R., Vallotton, P., Wohland, T., & Vogel, H. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01503-0 · Cited by 102
Králíková, M., Prézeau, L., Duthey, B., Bettler, B., Pin, J., & Blahoš, J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.343 · Cited by 98
V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules
Champigneulle, A., Siga, E., Vassent, G., & Imbert–Teboul, M. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.265.1.f35 · Cited by 80
Wurch, T., Matsumoto, A., & Pauwels, P. J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02969-6 · Cited by 48
Fluorescent Pseudo-Peptide Linear Vasopressin Antagonists: Design, Synthesis, and Applications,
Durroux, T., Peter, M., Turcatti, G., Chollet, A., Balestre, M., Barberis, C., & Seyer, R. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9804782 · Cited by 31
Self-citationLabelling of vasopressin and oxytocin receptors from the human uterus
Tencé, M., Guillon, G., Bottari, S. P., & Jard, S. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)94177-y · Cited by 28
Immunolocalization of V1 vasopressin receptors in the rat kidney using anti-receptor antibodies
González, C. B., Figueroa, C. D., Reyes, C. E., Caorsi, C. E., Troncoso, S., & Menzel, D. (1997) · Kidney International · doi:10.1038/ki.1997.445 · Cited by 24
Arpin‐Bott, M., Waltisperger, E., Freund‐Mercier, M. J., & Stoeckel, M. E. (1999) · The Nephron journals/Nephron journals · doi:10.1159/000045476 · Cited by 19
Clerget-Froidevaux, M.-S., Elalouf, J., & Germain, G. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00218-9 · Cited by 13
Cited by
The oxytocin receptor: from intracellular signaling to behavior
Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999
Roles of G‐protein‐coupled receptor dimerization: From ontogeny to signalling regulation
Terrillon, S., & Bouvier, M. (2004) · EMBO reports · doi:10.1038/sj.embor.7400052 · Cited by 683
Self-citationPfleger, K. D. G., & Eidne, K. A. (2006) · Nature Methods · doi:10.1038/nmeth841 · Cited by 569
G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology
Milligan, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000497 · Cited by 474
Bulenger, S., Marullo, S., & Bouvier, M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.004 · Cited by 448
Self-citation
Metadata
- Authors
- Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan, M., Jockers, R., Barberis, C., & Bouvier, M.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-04
- Volume
- 17
- Issue
- 4
- Pages
- 677-691
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2081819792
- Cited by
- 322
- References
- 49
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.